PMC:7253482 / 25933-26258
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
830 | 72-77 | Species | denotes | HIV-1 | Tax:11676 |
831 | 55-61 | Chemical | denotes | glycan | MESH:D011134 |
832 | 317-324 | Chemical | denotes | glycans | MESH:D011134 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T143 | 72-75 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T144 | 288-295 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T161 | 132-137 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T162 | 200-207 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | Viruses |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T249 | 288-295 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T250 | 317-324 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T81 | 132-137 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T82 | 200-207 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | Viruses |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T60855 | 0-2 | IN | denotes | In |
T15145 | 3-11 | NN | denotes | contrast |
T83757 | 11-12 | -COMMA- | denotes | , |
T41451 | 13-16 | DT | denotes | the |
T95094 | 17-21 | JJ | denotes | high |
T76290 | 22-30 | NN | denotes | mutation |
T92271 | 31-37 | NN | denotes | rate66 |
T59290 | 38-41 | CC | denotes | and |
T46337 | 42-45 | DT | denotes | the |
T52476 | 46-54 | VBG | denotes | evolving |
T10675 | 55-61 | NN | denotes | glycan |
T18714 | 62-68 | NN | denotes | shield |
T37792 | 69-71 | IN | denotes | of |
T21845 | 72-82 | NN | denotes | HIV-120,39 |
T87196 | 82-83 | -COMMA- | denotes | , |
T16269 | 84-89 | WDT | denotes | which |
T23317 | 90-96 | RB | denotes | firmly |
T90485 | 97-108 | VBZ | denotes | exemplifies |
T49535 | 109-111 | PRP | denotes | it |
T16896 | 112-114 | IN | denotes | as |
T63209 | 115-123 | NN | denotes | “evasion |
T42025 | 124-131 | NN | denotes | strong” |
T63465 | 132-137 | NN | denotes | virus |
T4468 | 137-138 | -COMMA- | denotes | , |
T1830 | 139-146 | VBZ | denotes | hinders |
T56636 | 147-150 | DT | denotes | the |
T80263 | 151-162 | NN | denotes | development |
T21297 | 163-165 | IN | denotes | of |
T77941 | 166-173 | RB | denotes | broadly |
T47145 | 174-186 | VBG | denotes | neutralizing |
T48978 | 187-207 | NNS | denotes | antibodies67.Viruses |
T78349 | 208-218 | VBN | denotes | classified |
T84508 | 219-221 | IN | denotes | as |
T99687 | 222-230 | NN | denotes | “evasion |
T94485 | 231-243 | NN | denotes | strong”26,56 |
T8371 | 244-247 | MD | denotes | may |
T70765 | 248-252 | RB | denotes | then |
T19557 | 253-259 | VB | denotes | differ |
T68211 | 260-263 | JJ | denotes | due |
T58964 | 264-266 | TO | denotes | to |
T91845 | 267-273 | JJ | denotes | varied |
T28724 | 274-284 | NNS | denotes | efficacies |
T35775 | 285-287 | IN | denotes | of |
T42494 | 288-295 | NN | denotes | protein |
T48391 | 296-303 | NN | denotes | surface |
T91764 | 304-313 | NN | denotes | shielding |
T1369 | 314-316 | IN | denotes | by |
T1370 | 317-324 | NNS | denotes | glycans |
R70746 | T1830 | T60855 | arg1Of | hinders,In |
R57447 | T15145 | T60855 | arg2Of | contrast,In |
R82201 | T1830 | T83757 | arg1Of | hinders,"," |
R18543 | T92271 | T41451 | arg1Of | rate66,the |
R93264 | T92271 | T95094 | arg1Of | rate66,high |
R8642 | T92271 | T76290 | arg1Of | rate66,mutation |
R7092 | T92271 | T59290 | arg1Of | rate66,and |
R24584 | T18714 | T59290 | arg2Of | shield,and |
R72489 | T18714 | T46337 | arg1Of | shield,the |
R76166 | T18714 | T52476 | arg1Of | shield,evolving |
R37843 | T18714 | T10675 | arg1Of | shield,glycan |
R59613 | T18714 | T37792 | arg1Of | shield,of |
R69771 | T21845 | T37792 | arg2Of | "HIV-120,39",of |
R38925 | T18714 | T87196 | arg1Of | shield,"," |
R46559 | T18714 | T16269 | arg1Of | shield,which |
R78632 | T90485 | T23317 | arg1Of | exemplifies,firmly |
R80497 | T18714 | T90485 | arg1Of | shield,exemplifies |
R82405 | T49535 | T90485 | arg2Of | it,exemplifies |
R44853 | T90485 | T16896 | arg1Of | exemplifies,as |
R46661 | T63465 | T16896 | arg2Of | virus,as |
R81667 | T63465 | T63209 | arg1Of | virus,“evasion |
R13160 | T63465 | T42025 | arg1Of | virus,strong” |
R63988 | T1830 | T4468 | arg1Of | hinders,"," |
R82299 | T59290 | T1830 | arg1Of | and,hinders |
R71846 | T19557 | T1830 | arg2Of | differ,hinders |
R93165 | T80263 | T56636 | arg1Of | development,the |
R55292 | T80263 | T21297 | arg1Of | development,of |
R1386 | T48978 | T21297 | arg2Of | antibodies67.Viruses,of |
R1387 | T47145 | T77941 | arg1Of | neutralizing,broadly |
R1388 | T48978 | T47145 | arg1Of | antibodies67.Viruses,neutralizing |
R1389 | T48978 | T78349 | arg2Of | antibodies67.Viruses,classified |
R1390 | T78349 | T84508 | arg1Of | classified,as |
R1391 | T94485 | T84508 | arg2Of | "strong”26,56",as |
R1392 | T94485 | T99687 | arg1Of | "strong”26,56",“evasion |
R1393 | T80263 | T8371 | arg1Of | development,may |
R1394 | T19557 | T8371 | arg2Of | differ,may |
R1395 | T19557 | T70765 | arg1Of | differ,then |
R1396 | T80263 | T19557 | arg1Of | development,differ |
R1397 | T58964 | T68211 | arg1Of | to,due |
R1398 | T19557 | T58964 | arg1Of | differ,to |
R1399 | T28724 | T58964 | arg2Of | efficacies,to |
R1400 | T28724 | T91845 | arg1Of | efficacies,varied |
R20306 | T28724 | T35775 | arg1Of | efficacies,of |
R1402 | T91764 | T35775 | arg2Of | shielding,of |
R1403 | T91764 | T42494 | arg1Of | shielding,protein |
R1404 | T91764 | T48391 | arg1Of | shielding,surface |
R22078 | T91764 | T1369 | arg1Of | shielding,by |
R1406 | T1370 | T1369 | arg2Of | glycans,by |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T142 | 72-75 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T143 | 288-295 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T167 | 288-295 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T168 | 317-324 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T186 | 72-75 | Species | denotes | HIV | NCBItxid:57667|NCBItxid:35274|NCBItxid:12721|NCBItxid:11709|NCBItxid:11676 |
T191 | 200-207 | Species | denotes | Viruses | NCBItxid:10239 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T146 | 0-325 | Sentence | denotes | In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
831 | 55-61 | Chemical | denotes | glycan | MESH:D011134 |
830 | 72-77 | Species | denotes | HIV-1 | Tax:11676 |
832 | 317-324 | Chemical | denotes | glycans | MESH:D011134 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T146 | 0-325 | Sentence | denotes | In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans. |